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doi:10.1016/j.jmii.2011.12.024Background: Patients with diabetes mellitus have an increased risk of infection. The roles of
bacterial characteristics and glycemic control in diabetic patients with Escherichia coli infec-
tion have not been well investigated. The aims of this study were to examine the bacterial
characteristics and glycemic control in diabetic patients with E. coli infections arising in the
urinary tract.
Methods: A total of 271 E. coli isolates were collected from urine and bloodstream. Phyloge-
netic groups, the presence of virulence genes, and antimicrobial susceptibility of E. coli
isolates were determined.
Results: There were few differences in E. coli bacterial characteristics between 190 diabetic
and 81 nondiabetic patients. In diabetic patients with urosepsis, there was a higher hemo-
globin A1C level, and the related E. coli strains had more neuA, papG II, afa and hlyA genes,
and a lower prevalence of antimicrobial resistance to cephalosporins and fluoroquinolones
than those with asymptomatic bacteriuria and urinary tract infection. Multivariate logistic
regression analysis revealed that increased hemoglobin A1C and presence of papG II and afat of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung
nan 70101, Taiwan.
du.tw (J.-J. Wu).
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E. coli urosepsis and glycemic control in diabetes 25genes were independent factors associated with development of urosepsis in diabetic patients.
Conclusion: This study demonstrated that more virulent E. coli isolates, especially with papG II
and afa genes, and poorer glycemic control were important determinants for development of
urosepsis in diabetic patients.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Escherichia coli is the major pathogen in many extra-
intestinal Gram-negative bacillus infections. Several viru-
lence factors of E. coli are responsible for colonization and
invasion of the host, and/or serve to avoid or disrupt host
defense mechanisms. Both E. coli virulence characteristics
and host factors contribute to the development of E. coli
bacteremia in upper urinary tract infection (UTI).1
Patients with diabetes mellitus have an increased risk for
infections, including UTI, soft tissue infections, community-
acquired pneumonia, necrotizing otitis externa, and
bloodstream infections.2,3 Impaired host defense, in both
cell-mediated immunity and humoral immunity, increases
the susceptibility to infection. Diabetes-associated func-
tional and anatomical abnormalities of the host also
contribute to it. Poor glycemic control increases the risk of
community-acquired infections and acquiring asymptom-
atic bacteriuria (ABU).4,5 Diabetes with poor glycemic
control and urinary tract obstruction are important host
factors predisposing to emphysematous pyelonephritis.6 In
most E. coli extraintestinal infections, host immunocom-
petence is associated with a relatively high prevalence of
papG II, afa and iha, and relatively low antimicrobial
resistance to fluoroquinolones.7
The role of bacterial characteristics and glycemic
control in diabetic patients with E. coli infections related to
urinary tract has not been well investigated. The aims of
this study were to examine and compare the bacterial
characteristics and glycemic control in diabetic patients
with E. coli infections arising in the urinary tract.Materials and methods
Subjects and bacterial strains
A total of 271 E. coli random isolates from urine or blood-
stream of patients with urinary-tract-related colonization
or infection at National Cheng Kung University Hospital,
Taiwan were collected from July 2005 to December
2009.They were derived from 81 nondiabetic and 190 dia-
betic patients with available glycated hemoglobin (HbA1C)
values within 3 months before collection of E. coli isolates.
Only one isolate per patient was accepted. Diabetes mel-
litus was diagnosed if fasting plasma glucose concentration
was  7.0 mmol/L (126 mg/dL) on two separate occasions,
or if the patient was being treated with insulin or oral
hypoglycemic agents. ABU was defined as bacterial coloni-
zation of urine in the absence of clinical symptoms. UTI was
diagnosed as a quantitative culture of  105 CFU/mL for E.
coli isolated from midstream urine or catheterization, andpresence of symptoms or signs of lower UTI (i.e., urgency
and frequency of urination, dysuria, and/or lower abdom-
inal pain with normal body temperature) or upper UTI (i.e.,
body temperature  38.3C, flank pain, and/or tenderness
of the costovertebral angle). Urosepsis was defined as
a patient with E. coli bacteremia arising from a urinary
tract source.
The E. coli strains collected from urine and bloodstream
were identified using standard methods, and stored in
20% glycerol at e70C until used in all subsequent analyses.
Susceptibility of E. coli strains, using the disk diffusion
method and interpretive criteria according to the Clinical
and Laboratory Standards Institute guidelines of 2006,
was determined to ampicillin, gentamicin, cefazolin,
second-generation cephalosporins (cefuroxime, cefoxitin or
cefmetazole), third-generation cephalosporins (cefotax-
ime, ceftriaxone, ceftazidime, cefixime or cefpodoxime),
fourth-generation cephalosporins (cefepime or cefpirome),
and fluoroquinolones (ciprofloxacin, levofloxacin or lome-
floxacin). Intermediate susceptibility was interpreted as
resistance.
Detection of E. coli K1 capsule and virulence genes
K1 capsule and 14 uropathogenic virulence factor genes of
E. coli were detected using polymerase chain reaction
(PCR). Primer pairs specific for K1 capsule gene, neuA, were
K1-F: ATGATTACTCGACACTGTC; K1-R: AACAATCTCCGCT
ATTTCG. The size of the PCR products was 812 bp. Primer
pairs specific for the three PapG adhesion genes (papG
class IeIII) of P-fimbriae and genes for type 1 fimbrial
adhesions (fimH ), S-/F1C-fimbriae (sfa/foc), afimbrial
adhesions (afa), iron-regulated gene A homolog adhesion
(iha), hemolysin (hlyA), cytotoxic necrotizing factor 1
(cnf1), catecholate siderophore receptor (iroN ), aero-
bactin receptor (iutA), outer membrane protease T
(ompT ), and uropathogenic specific protein (usp) have
been described previously.6 The extraction of bacterial DNA
and DNA amplification were performed. PCRs were carried
out in duplicate and positive and negative control strains
for the traits of interest were included in each assay.6
Phylogenetic analysis
The phylogenetic grouping of the E. coli isolates was
determined by a PCR-based method developed by Clermont
et al.8 The presence of the chuA and yjaA genes and DNA
fragment TSPE4.C2 was examined and E. coli isolates were
assigned to one of the four main phylogenetic groups (A,
B1, B2 or D). These results were further confirmed using
a dot-blot assay. Fifty microliters of extracted E. coli DNA
was pipetted onto a nitrocellulose membrane together with
Table 2 Host and bacterial characteristics of Escherichia









ABU/UTI/urosepsis 23/29/29 40/68/82 0.356
Age (y) 66 17 69 12 0.188
Sex (female) 65 (80) 148 (78) 0.747
26 M.-C. Wang et al.an equal volume of 0.2 N NaOH added to the DNA sample.
The DNA was incubated at room temperature for 10
minutes, and the membrane washed with 50 mL buffer
[0.5 M TriseHCl (pH 7.5), 1.5 M NaCl solution] per well, and
a vacuum was applied for 30 minutes. The DNA was cross-
linked using a UV cross-linker device (Amersham Biosci-
ences, Piscataway, NJ, USA) and the membrane rinsed with
2 SSC buffer (30 mM sodium citrate, pH 7.0, 0.3 M NaCl).
After hybridization reaction with a DNA probe at 60 C for 1
hour, the membrane was exposed overnight to film for
autoradiography.
Statistical analysis
The Pearson c2 test or Fisher’s exact test (2-tailed) was
used for comparison of categorical variables, whereas the
Wilcoxon rank sum test or one-way analysis of variance was
used for comparison of continuous variables. Multivariate
logistic regression analysis was used to assess the inde-
pendent factors for development of E. coli urosepsis in
diabetic patients. P< 0.05 was considered statistically
significant. All statistical analyses were performed using
JMP software (SAS Institute, Cary, NC, USA).
Results
There were 63 ABU and 97 UTI E. coli strains derived from
urine, and the number of E. coli strains from urosepsis was
111. Phylogenetic group B2 was the most common. The
overall antimicrobial resistance rate was 77% for ampicillin,Table 1 Demographic data of host and bacterial charac-
teristics of urinary-tract-related Escherichia coli isolates
Total nZ 271
Host characteristic
Age (y) 68 14
Sex (female) 213 (79)
Diabetes mellitus 190 (70)
Hemoglobin A1C (%) of diabetic patients 8.0 2.1
Asymptomatic bacteriuria 63 (23)












Second-generation cephalosporins 59 (22)
Third-generation cephalosporins 56 (21)
Fourth-generation cephalosporins 31 (11)
Fluoroquinolones 86 (32)
Data are presented as mean standard deviation or number
(percentage).33% for gentamicin, 30% for cefazolin, and 32% for fluo-
roquinolones (Table 1).
The sources of E. coli isolates and age and sex of the
hosts were similar between diabetic and nondiabetic
groups. Phylogenetic group B2 was most common in E. coli
isolates. There was no significant difference in the overall
virulence factors between the diabetic and nondiabetic
groups, except a greater prevalence of afa gene in the
diabetic group (Table 2).
The mean HbA1C value was highest in diabetic patients
with urosepsis. Phylogenetic group B2 was most common in
E. coli strains arising from a urinary tract source derived
from diabetic patients. Virulence factor genes with neuA,
papG II, afa and hlyA were more common in the urosepsis
isolates, whereas they were relatively low in the ABU
isolates (Table 3). Using HbA1C and neuA, papG II, afa and
hlyA genes as confounding variables for development of E.
coli urosepsis, multiple logistic regression analysis revealedBacterial characteristic
Phylogenetic group 0.855
A 8 (10) 23 (12)
B1 15 (19) 28 (15)
B2 40 (49) 96 (51)
D 18 (22) 43 (23)
K1 capsule, neuA 24 (30) 37 (19) 0.081
Adhesin
papG I 0 0 d
papG II 34 (42) 57 (30) 0.068
papG III 6 (7) 22 (12) 0.386
fimH 76 (94) 183 (96) 0.351
sfa 3 (4) 12 (6) 0.564
foc 3 (4) 12 (6) 0.564
afa 25 (31) 100 (53) 0.001
iha 31 (38) 68 (36) 0.783
Toxin
hlyA 16 (20) 35 (18) 0.865
cnf1 10 (12) 28 (15) 0.704
Siderophore
iroN 34 (42) 74 (39) 0.685
iutA 56 (69) 125 (66) 0.673
Miscellaneous
ompT 67 (83) 144 (76) 0.263
usp 47 (58) 100 (53) 0.428
Data are presented as mean standard deviation or number
(percentage).
ABUZ asymptomatic bacteriuria; UTIZ urinary tract infection.
Table 3 Host and bacterial characteristics of 190










Age (y) 70 9 71 13 66 12 0.070
Sex (female) 34 (85) 56 (82) 58 (71) 0.111
HbA1C (%) 7.5 1.5 7.7 2.0 8.5 2.3 0.013
Bacterial characteristic
Phylogenetic group 0.121
A 6 (15) 12 (18) 5 (6)
B1 7 (18) 10 (15) 11 (13)
B2 18 (45) 37 (54) 41 (50)
D 9 (23) 9 (13) 25 (30)
K1 capsule, neuA 5 (13) 9 (13) 23 (28) 0.034
Adhesin
papG I 0 0 0 d
papG II 4 (10) 13 (19) 40 (49) <0.0001
papG III 4 (10) 6 (9) 12 (15) 0.509
fimH 39 (98) 63 (93) 81 (99) 0.126
sfa 3 (8) 2 (3) 7 (9) 0.352
foc 0 7 (10) 5 (6) 0.104
afa 11 (28) 30 (44) 59 (72) <0.0001
iha 13 (33) 22 (32) 33 (40) 0.536
Toxin
hlyA 2 (5) 14 (21) 19 (23) 0.044
cnf1 3 (8) 11 (16) 14 (17) 0.344
Siderophore
iroN 14 (35) 27 (40) 33 (40) 0.845
iutA 24 (60) 45 (66) 56 (68) 0.661
Miscellaneous
ompT 29 (73) 48 (71) 67 (82) 0.246
usp 17 (43) 40 (59) 43 (52) 0.260
Data are presented as mean standard deviation or number
(percentage).
ABUZ asymptomatic bacteriuria; HbA1CZ glycated hemo-
globin; UTIZ urinary tract infection.
Table 4 Host and bacterial characteristics of Escherichia









Age (y) 63 19 64 20 72 14 0.199
Sex (female) 20 (87) 22 (76) 23 (79) 0.600
Bacterial characteristic
Phylogenetic group 0.466
A 2 (9) 4 (14) 2 (7)
B1 6 (26) 7 (24) 2 (7)
B2 10 (43) 12 (41) 18 (62)
D 5 (22) 6 (21) 7 (24)
K1 capsule, neuA 4 (17) 7 (24) 13 (45) 0.071
Adhesin
papG I 0 0 0 d
papG II 5 (22) 9 (26) 20 (69) 0.0009
papG III 4 (17) 1 (3) 1 (3) 0.097
fimH 21 (91) 27 (93) 28 (97) 0.722
sfa 2 (9) 0 1 (3) 0.256
foc 0 3 (10) 0 0.061
afa 1 (4) 6 (21) 18 (62) <0.0001
iha 6 (26) 9 (31) 16 (55) 0.061
Toxin
hlyA 4 (17) 4 (14) 8 (28) 0.396
cnf1 4 (17) 3 (10) 3 (10) 0.685
Siderophore
iroN 6 (26) 16 (55) 12 (41) 0.107
iutA 13 (57) 20 (69) 23 (79) 0.210
Miscellaneous
ompT 15 (65) 26 (90) 26 (90) 0.032
usp 12 (52) 17 (59) 18 (62) 0.770
Data are presented as mean standard deviation or number
(percentage).
ABUZ asymptomatic bacteriuria; UTIZ urinary tract infection.
E. coli urosepsis and glycemic control in diabetes 27that HbA1C [odds ratio (OR) per unit change: 1.3, 95%
confidence interval (CI): 1.1e1.6, pZ 0.0059), papG II (OR:
5.8, 95% CI: 2.4e14.2, pZ 0.0001), and afa (OR: 6.5, 95%
CI: 3.1e13.7, p< 0.0001] were associated with E. coli
urosepsis in diabetic patients. The results of host and
bacterial characteristics of E. coli isolates in 81 nondiabetic
patients in relation to ABU, UTI and urosepsis are shown in
Table 4. Virulence factor genes with papG II, afa and ompT
were more common in the urosepsis isolates, whereas they
were relatively low in the ABU isolates.
The prevalence of antimicrobial resistance of E. coli
isolates to second- and third-generation cephalosporins
was more common in the diabetic group compared to that
in the nondiabetic group. There was a trend towards
decline in antimicrobial resistance to cefazolin, second-
and third-generation cephalosporins, and fluoroquinolones
associated with the increased severity of E. coli-related
infection. The lowest rate of antimicrobial resistance of E.
coli isolates was in the urosepsis subgroup (Table 5). Therewas no significant difference in antimicrobial resistance
among the three groups in the nondiabetic patients
(Table 5).
Discussion
This study addressed the bacterial characteristics and
glycemic control in diabetic patients with E. coli infec-
tions arising in the urinary tract. Poorer glycemic control
contributed to development of urosepsis. In diabetic
patients with urosepsis, the corresponding E. coli isolates
were more virulent but less resistant to antibiotics than
those from diabetic patients with ABU or UTI. Bacterial
characteristics including papG II and afa genes were
important virulence factors for development of E. coli
urosepsis in diabetic patients.
It is well known that diabetic patients are immuno-
compromised and have an increased risk for different
infections. Glycemic control is an important outcome
indicator for diabetic patients with infection.9,10 Investi-
gations regarding bacterial characteristics and glycemic
Table 5 Antimicrobial resistance of urinary-tract-related Escherichia coli isolates
Diabetes mellitus (e) (nZ 81) Diabetes mellitus (þ) (nZ 190) p value
Ampicillin 57 (70) 153 (81) 0.081
Gentamicin 26 (32) 63 (33) 0.889
Cefazolin 22 (27) 58 (31) 0.663
Second-generation cephalosporins 11 (14) 48 (25) 0.037
Third-generation cephalosporins 10 (12) 46 (24) 0.033
Fourth-generation cephalosporins 12 (15) 19 (10) 0.298
Fluoroquinolones 20 (25) 66 (35) 0.118
Diabetes group (nZ 190) ABU (nZ 40) UTI (nZ 68) Urosepsis (nZ 82) p value
Ampicillin 33 (83) 59 (87) 61 (74) 0.153
Gentamicin 17 (43) 25 (37) 21 (26) 0.130
Cefazolin 17 (43) 25 (37) 16 (20) 0.013
Second-generation cephalosporins 14 (35) 22 (32) 12 (15) 0.013
Third-generation cephalosporins 13 (33) 21 (31) 12 (15) 0.027
Fourth-generation cephalosporins 4 (10) 11 (16) 4 (5) 0.072
Fluoroquinolones 20 (50) 29 (43) 17 (21) 0.001
Non-diabetes group (nZ 81) ABU (nZ 23) UTI (nZ 29) Urosepsis (nZ 29) p value
Ampicillin 16 (70) 22 (76) 19 (66) 0.686
Gentamicin 7 (30) 10 (34) 9 (31) 0.942
Cefazolin 6 (26) 5 (17) 11 (38) 0.206
Second-generation cephalosporins 5 (22) 4 (14) 2 (7) 0.300
Third-generation cephalosporins 5 (22) 4 (14) 1 (3) 0.132
Fourth-generation cephalosporins 5 (22) 5 (17) 2 (7) 0.294
Fluoroquinolones 8 (35) 8 (28) 4 (14) 0.198
Data are presented as mean standard deviation or number (percentage).
ABUZ asymptomatic bacteriuria; UTIZ urinary tract infection.
28 M.-C. Wang et al.control in E. coli-related infections arising in the urinary
tract have been scarce. HbA1C level as indicator of glycemic
control reported in many studies was measured following
admission or diagnosis of infection, which is difficult to
understand the glycemic control prior to the development
of infection. The present study included 190 diabetic
patients with available HbA1C values within 3 months before
collection of E. coli isolates, related to colonization or
infection of the urinary tract. This study demonstrated that
diabetic patients with urosepsis had the highest HbA1C
values compared to that in the ABU and UTI groups.
Besides, HbA1C value was an independent determinant for
occurrence of urosepsis. These results emphasized an
important role of glycemic control in the development of
E. coli urosepsis in diabetic patients.
There are few data concerning the bacterial character-
istics in diabetic patients with E. coli bacteremia. Previous
studies have shown that the distribution of bacterial viru-
lence factors depends on the primary source of E. coli
bacteremia, and greater prevalence of most virulence
characteristics contributes to the occurrence of E. coli
bacteremia.1,11 However, several studies have revealed no
significant difference in bacterial determinants between
patients with and without E. coli bacteremia.12e14 The
present study demonstrated a similar bacterial virulence
profile in diabetic and nondiabetic patients. E. coli isolates
from urosepsis exhibited a significantly greater prevalence
of neuA, papG II, afa and hlyA genes than nonurosepsis
isolates in diabetic patients. Using multivariate logic
regression analysis, we demonstrated that papG II and afagenes, but not neuA and hlyA genes, were important
determinants for E. coli urosepsis in diabetic patients. The
present study suggests that more bacterial virulence traits
may be necessary for development of E. coli urosepsis in
diabetic patients, and that papG II and afa genes are the
important bacterial virulence factors.
Meiland et al have reported lower antimicrobial resis-
tance rates in E. coli isolated from urine of diabetic women
than those from urine samples of the general female pop-
ulation.15 Bonadio et al have found that E. coli isolates are
resistant at similar rates to ampicillin, cotrimoxazole,
ciprofloxacin and nitrofurantoin in both diabetic and
nondiabetic patients.16 They have concluded that diabetes
mellitus per se does not seem to influence the susceptibility
patterns of uropathogens to antimicrobials.16 With very few
exceptions, there have been no differences observed in the
antimicrobial resistance profiles between diabetic and
nondiabetic groups.17 The present study showed a similar
antimicrobial resistance profile between diabetic and
nondiabetic patients, except for a higher resistance rate to
the second- and third-generation cephalosporins in the
diabetic group. The lowest rate of resistance to cefazolin,
second- and third-generation cephalosporins, and fluo-
roquinolones was found in the urosepsis-related E. coli
isolates derived from diabetic patients. These data do not
allow us to infer causality between antimicrobial resistance
and different E. coli infections. Compared to diabetic
patients with asymptomatic bacteriuria or UTI without
bacteremia, diabetic patients with urosepsis might have
received antimicrobial agents with stronger potency, higher
E. coli urosepsis and glycemic control in diabetes 29dose, and/or longer duration to eradicate the E. coli from
the bloodstream. The probability of antimicrobial-resistant
E. coli strains remaining in the urinary tract of diabetic
patients with urosepsis is lower than that in diabetic
patients with ABU or UTI.
The main limitation of this study was its retrospective
inclusion of diabetic patients with HbA1C examined within 3
months before collection of E. coli strains, which may have
affected the distribution of bacterial sources, virulence
characteristics, and antimicrobial resistance profiles of
E. coli isolates. In addition, diabetes and glycemic control
were the main host factors investigated for association with
the bacterial characteristics and E. coli infections. The role
of other important host factors, such as anatomical defects
and immunodeficiency, in the development of infection
could not be overlooked, although they were not included
for analysis in this study because of insufficient information
from chart records.
In conclusion, this study demonstrated the important
roles of glycemic control and bacterial characteristics in
E. coli infections arising in the urinary tract in diabetic
patients. More virulence characteristics of E. coli isolates,
especially those with papG II and afa genes, and poorer
glycemic control were significantly associated with devel-
opment of E. coli urosepsis in diabetic patients.
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